Posts filtered by tags: Medical Device[x]


 

Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More

Diabetes drugs are Eli Lilly’s bread and butter, but the pharmaceutical giant hasn’t lost its appetite for cancer drugs. It grabbed hold of a few more this week by betting $8 billion on Loxo Oncology.Loxo (NASDAQ: LOXO) has made a name for itself by becoming one of just two companies ever to earn an FDA approval for a drug that targets a tumor’s DNA fingerprint, no matter where in the body that cancer is found. The drug, larotrectinib, targets rare tumor abnormalities known as NTRK fusions. The...
Tags: Deals, Startups, Ipo, Cancer, Trends, Medicare, SEC, Fda, National, GlaxoSmithKline, Allergan, Shire, Biotech, Medical Device, Postpartum Depression, Bernie Sanders


Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests

Beta Bionics, a startup developing a medical device that monitors and manages blood sugar levels in diabetes patients, has closed $63 million to back late-stage clinical tests of its AI-powered technology.The cash tops off a Series B round of funding announced last year. The Boston company, which counts diabetes drug giants Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) among its investors and partners, says the capital will support Phase 3 studies of its device this year, and if all goes w...
Tags: Deals, Startups, Boston, Trends, Investing, Vc, Software, Diabetes, Venture Capital, Fda, Biotech, Novo Nordisk, Medical Device, Wearable Devices, Medtech, Life Sciences


RiverVest Venture Closes $184M Fund for Backing Healthcare Ventures

RiverVest Venture Partners, a St. Louis, MO-based venture capital firm with additional offices in San Diego, CA, and Cleveland, OH, has raised $184.4 million for its fourth fund dedicated to investing in healthcare companies.Since its launch, RiverVest has invested in 47 companies working to develop new drugs and medical devices. Nearly half of the businesses in its portfolio have either been acquired or gone public, according to RiverVest.Among the notable exits was San Diego’s Lumena Pharmace...
Tags: Deals, Money, Trends, Vc, Venture Capital, San Diego, Astrazeneca, Biotech, Medical Device, Life Sciences, Abbott Laboratories, San Diego CA, St Louis MO, Cleveland OH, Cambridge Associates, ZS Pharma


San Antonio Seeks to Be Known as Silicon Valley of Military Medicine

San Antonio — When it comes to medical technology, what’s good for the military isn’t always good for the private sector.It’s often difficult for military researchers to find investors who will help them privately commercialize the innovations they develop, in part because the duties of military physicians are different than those of civilian doctors. That’s the case when it comes to both treating patients and working with others to develop new healthcare tools. The military may want a product ...
Tags: Startups, Texas, Technology, Medicine, Entrepreneurship, Entrepreneur, Trends, Startup, Tech, People, Commercialization, Medical Research, Venture Capital, Silicon Valley, Fda, Medical Device


Nominations Open for San Diego’s Inaugural Xconomy Awards

Hundreds of companies. Dozens of research institutes. Billions of dollars in economic impact.San Diego is one of the top U.S. cities for innovation in life sciences and healthtech. Researchers and entrepreneurs here are leaders in developing the next generation of medicines and medical devices. In doing so, they are revealing new insights from our genomes, coming up with new data analytics tools, and applying digital advances to improve health.To celebrate this innovation in San Diego— in the l...
Tags: Startups, Trends, People, Vc, Venture Capital, San Diego, Biotech, Medical Device, Digital Health, Life Sciences, Healthtech, National blog main, National top stories, Xperience, Xconomy, San Diego blog main


ResMed To Add To Software Offerings With $750M MatrixCare Acquisition

Medical device maker ResMed has agreed to acquire Minnesota-based MatrixCare, which makes software for long-term care providers, for $750 million.San Diego’s ResMed (NYSE: ticker[[RMD]]) announced its intention to buy the privately held tech company on Monday. The purchase price is 25 times MatrixCare’s pro forma 2018 earnings of about $30 million (without taking into account interest, taxes, depreciation or amortization) on anticipated net revenue of about $122 million.ResMed, which brought in...
Tags: Deals, Minnesota, Cloud Computing, Trends, Software, Healthcare, SaaS, San Diego, M&a, Medical Device, Acquisition, Medtech, Life Sciences, Healthtech, Medical Equipment, Resmed


MR3 Health Takes Aim at Foot Ulcers as San Antonio Tackles Diabetes

San Antonio — Researchers, advocates, and residents in San Antonio have been seeking out ways to handle the growing problem of diabetes in San Antonio and the surrounding Bexar County, which saw the rate of adults with the condition increase to 14.2 percent in 2014 from 11.4 percent two years earlier. Both are higher than the state and national averages.Everything from experimental drugs to medical devices are being developed in town, including at startups like Syner-III and EO2 Concepts and at...
Tags: Startups, Texas, Bluetooth, Obesity, Trends, Startup, Research, Blood Flow, Ulcers, Diabetes, Fda, Medical Device, San Antonio, Life Sciences, Siren, Medical Devices


Delivery Robots in Big D, Rodriguez Leaves the Station, & More TX Tech

[Updated 2:05 p.m. See below.] Let’s catch up with the latest innovation news in Texas.—Dallas-based Neos Therapeutics (NASDAQ: NEOS) has licensed a drug candidate that would treat excessive salivation or drooling in patients with neurological conditions such as cerebral palsy, Parkinson’s disease, amyotrophic lateral sclerosis, and mental disorders. The experimental drug has only preclinical data so far. Neos is calling the drug NT0501, and licensed it from NeuRx Pharmaceuticals, which is base...
Tags: Startups, Apps, Utah, Texas, Drugs, Funding, San Francisco, Trends, Investment, People, Software, Austin, Innovation, Venture Capital, Tencent, Dallas


InCube, VelocityTX Join Work to Develop Pediatric Medical Devices

San Antonio—A group of San Antonio institutions are getting involved in an FDA program that seeks to distribute about $6.75 million worth of seed funding as well as business and product development advising to makers of pediatric medical devices.The program is called the Pediatric Device Consortia Grant Program. The FDA is handing out grants to five nonprofit consortia around the country over the next five years. The Southwest Pediatric Device Consortium, which represents organizations througho...
Tags: Startups, Texas, Trends, Startup, Engineering, Research and development, Food And Drug Administration, Fda, Medical Device, Grant, San Antonio, Texas A&M, Product Development, Sxsw, Life Sciences, Medical Devices


San Antonio’s Spinal Stabilization Technologies Snags $11M Funding

San Antonio—Spinal Stabilization Technologies, a company developing a medical device for degenerating spinal cord discs, has added almost $11.2 million in new financing, according to a securities filing.Founded in 2010, San Antonio-based SST is developing a lumbar implant that can replace the nucleus of a deteriorating spinal disc. People’s discs deteriorate as they age, in part because of our slowing cellular metabolism and also because of the loss of fluid from the nucleus, which can cause se...
Tags: Texas, Funding, Trends, Vc, Venture Capital, Food And Drug Administration, Fda, Medical Device, San Antonio, Venture Funding, Life Sciences, Spine, National blog main, Texas blog main, Texas top stories, Exome


Renovia Raises $42M to Back Digital Treatment for Incontinence

Renovia, a company aiming to turn the smartphone into a tool for treating incontinence, has closed $42.3 million in financing as it proceeds with clinical trials.Boston-based Renovia said Tuesday that the new capital consists of $32.2 million in equity funding and $10 million in venture debt. The equity financing, a Series B round of investment, was led by Perceptive Advisors and Ascension Ventures.Renovia focuses on treatments for pelvic floor disorders in women. The company markets the leva P...
Tags: Startups, Boston, Trends, Investing, Software, Fda, Women's Health, Biotech, Medical Device, Digital Health, Life Sciences, Clinical Trials, Ascension Ventures, Western Technology Investment, National blog main, Boston blog main


Bio Roundup: Duchenne Data, Roche Buys Foundation, IPO Wave & More

Biotech financing is a cyclical thing. Two years ago, the IPO window was unlatched but a number of companies ended up withdrawing their stock offerings. Others that pushed their IPOs through couldn’t sell shares at the price they wanted. This year, the IPO window is wide open. A total of 93 IPOs have priced as of Thursday, up 36.8 percent compared to the same time last year, according to Renaissance Capital. Healthcare leads all sectors, accounting for more than one-third of the IPOs this...
Tags: Amazon, Startups, Ipo, Trends, Investing, Venture Capital, Berkshire Hathaway, National, Biotech, Medical Device, Tim Draper, Theranos, Elizabeth Holmes, Life Sciences, Migraine, Charlie Baker


Strangeworks, TMCx, SeriesX, Unchained Capital, ALTR, & More TX Tech

Let’s get caught up with the latest innovation news from Xconomy Texas. —Strangeworks, an Austin, TX-based quantum computing startup, announced it has raised $4 million in a seed round led by Lightspeed Venture Partners, according to a press release. Ecliptic Capital, GreatPoint Ventures, Lux Capital, BoxGroup, and Amplify Partners contributed to the funding. Strangeworks, which was founded last year by William Hurley, is currently focusing on developing quantum tools related to the aeros...
Tags: Startups, Accelerator, Texas, Funding, Trends, Investment, People, Cybersecurity, Software, Austin, Innovation, Venture Capital, Streaming, Goldman Sachs, Houston, Medical Device


San Antonio Startup Adds Funding to Treat PTSD with Magnetic Field

San Antonio—An imaging researcher who hopes to improve a method of treating depression and post-traumatic stress disorder has raised a round of funding to support a clinical study for his San Antonio company’s medical device. The business, Cerebral Magnetics, told federal securities regulators on April 9 it was seeking to offer $1 million in an equity round of financing, though the company hadn’t sold anything in the offering yet. Peter Fox, the company’s founder, says the round will help...
Tags: Startups, Texas, Funding, Trends, Startup, Software, Brain, Depression, Ptsd, Veteran, Venture Capital, Fda, Robotics, Medical Device, Robot, Financing


United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed

Drug developer SteadyMed has been building momentum to take on the established seller of a therapy for a rare lung disease. But the rivalry could be over before it even started. Instead of competing against the United Therapeutics line-up of therapies for pulmonary arterial hypertension, SteadyMed’s lead drug is now in line to join them. United Therapeutics (NASDAQ: UTHR) announced Monday that it has reached a deal to acquire San Ramon, CA-based SteadyMed (NASDAQ: STDY) for $4.46 per shar...
Tags: Deals, Startups, San Francisco, Trends, Food And Drug Administration, Fda, Biotech, Medical Device, Life Sciences, San Ramon CA, United Therapeutics, National blog main, San Francisco blog main, San Francisco top stories, Raleigh-Durham blog main, UTHR


FDA Permits Marketing of First AI-based Medical Device; Signals Fast Track Approach to Artificial Intelligence

By Aaron Gin -- "The first and only autonomous AI system authorized by the FDA" On April 11, 2018, the U.S. Food and Drug Administration (FDA) permitted marketing of a medical device that utilizes artificial intelligence to diagnose eye disease in diabetic adults. The device, called IDx-DR from the company IDx, screens patients for diabetic retinopathy using deep learning algorithms. The screening involves standard retinal imaging, takes less than a minute, and can be performed without a clinici...
Tags: Law, Food And Drug Administration, Fda, Medical Device, U S Food and Drug Administration FDA, Patent Docs, Aaron Gin The


Boston Scientific Buys Securus for $40M to Add to Heart Imaging Lineup

Medical device giant Boston Scientific has acquired Securus Medical Group, a startup with FDA-cleared technology that measures and images temperature in the body during heart rhythm procedures. Marlborough, MA-based Boston Scientific (NYSE: BSX) said Tuesday that it paid $40 million up front for the stake in Securus that it did not already own. Securus, which is based in Cleveland, OH, and maintains a research site in Beverly, MA, could gain up to $10 million more, pegged to unspecified r...
Tags: Deals, Boston, Trends, Startup, Investing, Surgery, Food And Drug Administration, Fda, Medical Device, Life Sciences, Boston Scientific, Cleveland OH, Joe FitzGerald, SECURUS, National blog main, Boston blog main


Auris Health’s Surgical Robot Gets FDA Green Light for Lung Cancer

Auris Health is now the latest surgical robot company with the go-ahead to enter the U.S. market. The Redwood City, CA, based company, formerly known as Auris Surgical Robots, said Friday that its robotic system has cleared the FDA’s regulatory bar, allowing the system to be used for diagnosing and treating lung cancer tumors. The Auris robotic system, called Monarch, is based on endoscopy, which involves inserting tiny cameras and instruments through a small opening in the body, avoiding...
Tags: Startups, San Francisco, Trends, Software, Lung Cancer, Surgery, Fda, Biotech, Medical Device, Life Sciences, Redwood City CA, National blog main, San Francisco blog main, San Francisco top stories, Raleigh-Durham blog main, Mazor Robotics


PE-backed Z-Medica recruits Compton as president and CEO

Z-Medica LLC, a provider of hemostatic devices, has named Eric Compton as president and CEO. His appointment becomes effective March 5, 2018. Compton is a former chief operating officer of Hologic. Z-Medica is backed by Linden Capital Partners. PRESS RELEASE WALINGFORD, CONN. (PRWEB) FEBRUARY 27, 2018 Z-Medica, LLC, a leading developer and marketer of hemostatic devices, announces today the appointment of healthcare industry veteran Eric Compton as President and Chief Executive Officer effective...
Tags: Trends, People, Chicago, United States, Healthcare, West Coast, Medical Device, Steve, Compton, Eric, Johnson Johnson, Wallingford, Linden, Procter Gamble, Linden Capital Partners, Hologic


Cognoa’s AI platform for autism diagnosis gets first FDA stamp

 Cognoa has gained regulatory recognition for its machine learning software as a class II diagnostic medical device for autism — meaning the digital health startup is now positioned to submit an application for full FDA clearance. Read More
Tags: Health, TC, Apps, Tech, Artificial Intelligence, Autism, Food And Drug Administration, Machine Learning, Fda, Ai, Medical Device, Cognoa, Medical Technology


FDA OKs Banyan Diagnostic, the First Blood Test for Concussions

The FDA has approved the first blood test to help diagnose concussions, clearing a path to the market for a diagnostic that could reduce the use of expensive brain imaging technologies that expose patients to radiation. The approval goes to San Diego diagnostics developer Banyan Biomarkers. The company’s test, called Banyan BTI (short for brain trauma indicator), measures the levels of two proteins that the brain releases into the blood in the hours following a head injury. The company de...
Tags: Startups, Trends, San Diego, Food And Drug Administration, Fda, Biotech, Medical Device, Life Sciences, Clinical Trials, U.S. Army, Banyan Biomarkers, National blog main, National top stories, San Diego blog main, San Diego top stories, Diagnostic Device


Boston Scientific Pumps $90M Into Heart Device Startup Millipede

Boston Scientific is infusing medical device company Millipede with $90 million, an equity investment that comes with the option to acquire the startup outright. According to the agreement, Marlborough, MA-based Boston Scientific (NYSE: BSX) must exercise its option to acquire Millipede before the startup completes its ongoing clinical trial for its heart valve repair device—as long as that trial meets certain undisclosed parameters. If the acquisition does not happen by the end of the cl...
Tags: Deals, Boston, Trends, Investing, Food And Drug Administration, Fda, Biotech, Medical Device, Mayo Clinic, Life Sciences, University Of Michigan, Clinical Trials, BMO Capital Markets, Santa Rosa CA, Boston Scientific, National blog main


Eye Drug Delivery Firm Eyenovia Sets IPO Range as Plans Come Into Focus

Eyenovia, a startup that has adapted an inkjet printing technique into a way to deliver drugs to the eye, is providing more clarity on an initial public offering intended to finance late-stage clinical testing of its technology. New York-based Eyenovia plans to offer 2.73 million shares priced between $10 and $12 each, according to an updated prospectus filed with securities regulators. At the midpoint, the IPO would raise $30 million. The company has applied for a listing on the Nasdaq e...
Tags: Startups, New York, Ipo, Trends, Investing, Novartis, Biotech, Medical Device, Nasdaq, Initial Public Offering, Life Sciences, Drug Delivery, Clinical Trials, Genentech, Alcon, Ranibizumab


Swallow this ingestible gas sensor to spill the secrets of your angry gut

A new and tiny pill-sized device developed by researchers at RMIT University in Melbourne, Australia,  is actually a functioning ingestible gas sensor that could one day help save you from a severe gut-related problem. The post Swallow this ingestible gas sensor to spill the secrets of your angry gut appeared first on Digital Trends.
Tags: Trends, Medical Device, Health & Fitness, Emerging Tech, Melbourne Australia, RMIT University, Smart Sensor, Biomarkers


Ocular Therapeutics Hit by Subpoena, SEC Seeks Eye Pain Drug Documents

Federal securities regulators are asking questions about an Ocular Therapeutics eye pain product that was rejected by the FDA in July. Ocular (NASDAQ: OCUL) received a subpoena from the Securities and Exchange Commission dated Dec. 15, the Bedford, MA, company said Friday after the markets closed. The subpoena seeks documents and information regarding the company’s lead product candidate, Dextenza. In a news release, Ocular characterized the SEC communication as a “non-public, fact-findin...
Tags: Startups, Boston, Trends, Food And Drug Administration, SEC, Fda, Biotech, Medical Device, Securities And Exchange Commission, Life Sciences, Clinical Trials, National blog main, Boston blog main, Boston top stories, Dextenza, Dexamethasone


Ocular Therapeutix Hit by Subpoena, SEC Seeks Eye Pain Drug Documents

Federal securities regulators are asking questions about an Ocular Therapeutix eye pain product that was rejected by the FDA in July. Ocular (NASDAQ: OCUL) received a subpoena from the Securities and Exchange Commission dated Dec. 15, the Bedford, MA, company said Friday after the markets closed. The subpoena seeks documents and information regarding the company’s lead product candidate, Dextenza. In a news release, Ocular characterized the SEC communication as a “non-public, fact-finding...
Tags: Startups, Boston, Trends, Food And Drug Administration, SEC, Fda, Biotech, Medical Device, Securities And Exchange Commission, Life Sciences, Clinical Trials, National blog main, Boston blog main, Boston top stories, Dextenza, Dexamethasone


Bio Roundup: Graham-Cassidy, Axovant Fail, SpringWorks Launches & More

After drug pricing, count drug shortages among the hot button issues sparking patient ire. Last year, the FDA says, 23 drug shortages were , down from 26 the previous year (and 251 in 2011). But Hurricane Maria’s direct strike on Puerto Rico might put the progress made on reducing shortages to the test. The Pharmaceutical Industry Association of Puerto Rico lists 22 manufacturing sites on the island, operated by companies such as Amgen (NASDAQ: AMGN), Pfizer (NYSE:PFE), Bristol-Myers Squ...
Tags: Deals, Startups, Chris Christie, Ipo, Cancer, Trends, Investing, It, Harvard University, Alzheimer's Disease, Food And Drug Administration, Affordable Care Act, World Health Organization, Fda, National, Pfizer


Biomed Incubator Watershed Develops Tech for IDing Medical Devices

San Antonio — A biomedical product developer, Watershed Idea Foundry, has created a method of identifying medical devices that have been implanted in the body that uses 3-D printing and its own software. The technology, which Watershed calls structural encoding, prints 3-D codes onto small metal markers that are frequently included in medical devices, which help locate an implant in the body with an X-ray or MRI. The codes printed on those markers can include information about the medical...
Tags: Iphone, Startups, Texas, Trends, Startup, App, Software, Incubator, X-ray, Software Development, Fda, Implant, Medical Device, San Antonio, Application, Mri


A4L Lands $25M for Imaging Tech that Reads Heart’s Electric Signals

Electricity regulates the beats of a healthy human heart, telling its chambers when to contract. Though the role of electrical signals in heartbeats is well understood, Analytics 4 Life says they can offer much more. The startup has closed $25 million in financing to test a medical device meant to read the heart’s electrical activity to help clinicians make treatment decisions. The Series B announced Wednesday came from a group of unnamed private investors in the U.S., Europe, and China, ...
Tags: Deals, Startups, Europe, Life, China, Toronto, Trends, Investing, Analytics, It, Food And Drug Administration, Fda, Biotech, Medical Device, Amazon Web Services, Life Sciences


M&A News for the Healthcare Industry Sector

The report below provides a good overview of the 3rd Quarter M&A activity in the Healthcare Industry Sector. Q2 M&A activity for North American based Healthcare companies included 152 closed deals, according to data published by industry data tracker FactSet Research with an average disclosed transaction value of $142 million. One of the largest deals of the quarter closed in May when Sawai Pharmaceutical Co. Ltd. acquired Upsher-Smith Laboratories, Inc. from ACOVA, Inc., for US$1.1 Billion in c...
Tags: Business, US, Healthcare, M&a, Medical Device, Investment Banking, Upsher Smith Laboratories Inc, Corporate Finance, Entire Healthcare, FactSet Research, M&A advisor, Healthcare Industry Sector, Sawai Pharmaceutical Co Ltd, ACOVA Inc, Sawai Pharmaceutical Co, Upsher Smith Laboratories